We are live on ! Find out more
GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

123 hedge funds and large institutions have $582M invested in G1 Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 35 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

34% more capital invested

Capital invested by funds: $434M → $582M (+$148M)

23% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

2% less funds holding

Funds holding: 125 → 123 (-2)

17% less call options, than puts

Call options by funds: $10.9M | Put options by funds: $13.1M

Holders
123
Holders Change
-2
Holders Change %
-1.6%
% of All Funds
2.16%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
43
Reduced
35
Closed
25
Calls
$10.9M
Puts
$13.1M
Net Calls
-$2.22M
Net Calls Change
+$2.35M

Top Buyers

Rank Fund Capital Flow
1
CLOS
Compagnie Lombard Odier SCmA
Switzerland
+$14M
2
LOAMS
Lombard Odier Asset Management (Switzerland)
Switzerland
+$14M
3
Two Sigma Investments
Two Sigma Investments
New York
+$12.9M
4
TCM
Tekla Capital Management
Massachusetts
+$9.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$8.02M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$22.3M
2
Invesco
Invesco
Georgia
-$15.3M
3
MB
MPM BioImpact
Massachusetts
-$11.5M
4
Goldman Sachs
Goldman Sachs
New York
-$8.55M
5
HA
HHLR Advisors
Cayman Islands
-$8.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Rafferty Asset Management
26
Rafferty Asset Management
New York
$3.43M +$2.65M +113,946 +396%
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
$3.21M -$1.85M -79,470 -37%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$3.15M -$17.8K -768 -0.6%
RJA
29
Raymond James & Associates
Florida
$2.89M -$579K -24,933 -17%
Jane Street
30
Jane Street
New York
$2.88M +$2.16M +93,056 +350%
BCM
31
Burrage Capital Management
Massachusetts
$2.83M – – –
Renaissance Technologies
32
Renaissance Technologies
New York
$2.55M +$2.47M +106,100 New
PP
33
PDT Partners
New York
$2.22M -$147K -6,319 -6%
Wells Fargo
34
Wells Fargo
California
$1.89M +$849K +36,544 +87%
Citadel Advisors
35
Citadel Advisors
Florida
$1.84M -$2.37M -102,004 -57%
Ameriprise
36
Ameriprise
Minnesota
$1.76M -$380K -16,336 -18%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$1.67M – – –
UBS Group
38
UBS Group
Switzerland
$1.6M +$1.54M +66,258 +31,107%
Swiss National Bank
39
Swiss National Bank
Switzerland
$1.55M – – –
GG
40
Golden Green
South Carolina
$1.4M +$547K +23,538 +68%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$1.24M -$2.67K -115 -0.2%
CA
42
CHI Advisors
New York
$1.2M -$279K -12,000 -19%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$1.19M -$101K -4,357 -8%
SFI
44
Susquehanna Fundamental Investments
Pennsylvania
$1.11M +$1.07M +46,180 New
Los Angeles Capital Management
45
Los Angeles Capital Management
California
$1.11M -$1.68M -72,265 -61%
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$1.1M -$18.6K -800 -2%
SG Americas Securities
47
SG Americas Securities
New York
$1.09M +$357K +15,354 +51%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$1.07M – – –
RJFSA
49
Raymond James Financial Services Advisors
Florida
$977K +$25.2K +1,086 +3%
BC
50
Birchview Capital
Vermont
$962K – – –
1
2
3 4 5

GTHX Hedge Fund Activity: Q1 2021 in Review

123 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in G1 Therapeutics, Inc. Common Stock (GTHX) for Q1 2021, worth a combined $582M — up 34% from $434M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of GTHX and 24 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 43 added.

The largest buyer was Compagnie Lombard Odier SCmA, opening a new position worth an estimated $14M. The largest seller was Wellington Management Group, exiting entirely with an estimated $22.3M sold.

  • 123 institutional investors held G1 Therapeutics, Inc. Common Stock (GTHX) as of Q1 2021, down from 125 in Q4 2020.
  • Funds reported $582M of G1 Therapeutics, Inc. Common Stock stock for Q1 2021, up 34% quarter-over-quarter.
  • 24 funds opened new G1 Therapeutics, Inc. Common Stock positions in Q1 2021 and 25 closed out, a net change of -1 holder.
  • The largest G1 Therapeutics, Inc. Common Stock buyer in Q1 2021 was Compagnie Lombard Odier SCmA, an estimated $14M added.
  • The largest G1 Therapeutics, Inc. Common Stock seller in Q1 2021 was Wellington Management Group, an estimated $22.3M sold.

Based on aggregated 13F filings for Q1 2021.